Continuous processing is making its way into pharma and biotech. Over the past few years, there has been a surge of activities and progresses made in the industry globally. Through incremental steps, drug developers are moving through the journey of commercialising continuous manufacturing.
Join NNE at the 3rd annual CCP Summit and stay abreast of project updates and innovative developments.
The three-day summit offers tailored discussions and workshops to help you transform your manufacturing practice. One of workshops is lead by NNE's Morten Munk, Niels Guldager and Tommy Alfast and zeroes in on how to establish a robust design and quality control strategy for industrialising continuous bioprocessing.